thorium has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjerke, RM; Cuthbertson, AS; Hagemann, UB; Hammer, S; Hennekes, H; Karlsson, J; Mumberg, D; Ryan, OB; Scholz, A; Wickstroem, K; Zitzmann-Kolbe, S | 1 |
1 review(s) available for thorium and Hematologic Malignancies
| Article | Year |
|---|---|
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Topics: Alarmins; Alpha Particles; Chelating Agents; DNA Damage; Hematologic Neoplasms; Humans; Immunoconjugates; Immunogenic Cell Death; Precision Medicine; Pyridones; Radiopharmaceuticals; Thorium; Treatment Outcome | 2020 |